SBI Securities Co. Ltd. Buys New Shares in VanEck Pharmaceutical ETF (NASDAQ:PPH)

SBI Securities Co. Ltd. purchased a new position in VanEck Pharmaceutical ETF (NASDAQ:PPH) during the fourth quarter, HoldingsChannel.com reports. The fund purchased 332 shares of the company’s stock, valued at approximately $29,000.

A number of other large investors have also added to or reduced their stakes in the company. Townsquare Capital LLC grew its holdings in VanEck Pharmaceutical ETF by 3.8% in the 3rd quarter. Townsquare Capital LLC now owns 3,519 shares of the company’s stock worth $334,000 after acquiring an additional 130 shares during the last quarter. FMR LLC boosted its stake in shares of VanEck Pharmaceutical ETF by 12.5% during the 3rd quarter. FMR LLC now owns 1,905 shares of the company’s stock valued at $181,000 after purchasing an additional 212 shares in the last quarter. NTV Asset Management LLC boosted its stake in shares of VanEck Pharmaceutical ETF by 3.6% during the 4th quarter. NTV Asset Management LLC now owns 7,709 shares of the company’s stock valued at $665,000 after purchasing an additional 271 shares in the last quarter. Assetmark Inc. boosted its stake in shares of VanEck Pharmaceutical ETF by 5.8% during the 3rd quarter. Assetmark Inc. now owns 6,491 shares of the company’s stock valued at $617,000 after purchasing an additional 354 shares in the last quarter. Finally, Activest Wealth Management bought a new stake in shares of VanEck Pharmaceutical ETF during the 4th quarter valued at about $32,000.

VanEck Pharmaceutical ETF Trading Down 1.1 %

Shares of PPH opened at $91.50 on Thursday. The firm’s 50-day moving average price is $89.27 and its 200-day moving average price is $91.26. The firm has a market capitalization of $570.96 million, a price-to-earnings ratio of 30.55 and a beta of 0.72. VanEck Pharmaceutical ETF has a 1-year low of $84.48 and a 1-year high of $99.51.

VanEck Pharmaceutical ETF Increases Dividend

The business also recently announced a dividend, which was paid on Monday, December 30th. Stockholders of record on Friday, December 27th were paid a dividend of $0.411 per share. This is a positive change from VanEck Pharmaceutical ETF’s previous dividend of $0.36. The ex-dividend date of this dividend was Friday, December 27th.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.